|
[1]
|
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018) Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 392, 1789-1858.
|
|
[2]
|
Loehr, L.R., Rosamond, W.D., Chang, P.P., et al. (2008) Heart Failure Incidence and Survival (from the Atherosclerosis Risk in Communities Study). The American Journal of Cardiology, 101, 1016-1022. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Mosterd, A. and Hoes, A.W. (2007) Clinical Epidemiology of Heart Failure. Heart, 93, 1137-1146. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Van Riet Evelien, E.S., Hoes Arno, W., Wagenaar, K.P., et al. (2016) Epidemiology of Heart Failure: The Prevalence of Heart Failure and Ventricular Dysfunction in Older Adults over Time. A Systematic Review. European Journal of Heart Failure, 18, 242-252. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Groenewegen, A., Rutten, F.H., Mosterd, A., et al. (2020) Epidemiology of Heart Failure. European Journal of Heart Failure, 22, 1342-1356. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Lam, C.S., Donal, E., Kraigher-Krainer, E., et al. (2011) Epidemiology and Clinical Course of Heart Failure with Preserved Ejection Fraction. European Journal of Heart Failure, 13, 18-28. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Steinberg, B.A., Zhao, X., Heidenreich, P.A., et al. (2012) Trends in Patients Hospitalized with Heart Failure and Preserved Left Ventricular Ejection Fraction: Prevalence, Therapies, and Outcomes. Circulation, 126, 65-75. [Google Scholar] [CrossRef]
|
|
[8]
|
金雪娟, 周京敏, 葛均波. 心力衰竭流行病学的研究进展[J]. 中国临床医学, 2013, 20(6): 852-855.
|
|
[9]
|
Seferovic, P.M., Ponikowski, P., Anker, S.D., et al. (2019) Clinical Practice Update on Heart Failure 2019: Pharmacotherapy, Procedures, Devices and Patient Management. An Expert Consensus Meeting Report of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 21, 1169-1186. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Daubert, M.A., Whellan, D.J., Woehrle, H., et al. (2018) Treatment of Sleep-Disordered Breathing in Heart Failure Impacts Cardiac Remodeling: Insights from the CAT-HF Trial. American Heart Journal, 201, 40-48. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
D’Elia, E., Ferrero, P., Vittori, C., et al. (2019) Beneficial Effects of Adaptive Servo-Ventilation on Natriuretic Peptides and Diastolic Function in Acute Heart Failure Patients with Preserved Ejection Fraction and Sleep-Disordered Breathing. Sleep and Breathing, 23, 287-291. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Paitazoglou, C., Bergmann, M.W., Özdemir, R., et al. (2021) One-Year Results of the First-in-Man Study Investigating the Atrial Flow Regulator for Left Atrial Shunting in Symptomatic Heart Failure Patients: The Prelieve Study. European Journal of Heart Failure, 23, 800-810. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Mueller, S., Winzer, E.B., Duvinage, A., et al. (2021) Effect of High-Intensity Interval Training, Moderate Continuous Training, or Guideline-Based Physical Activity Advice on Peak Oxygen Consumption in Patients with Heart Failure with Preserved Ejection Fraction: A Randomized Clinical Trial. JAMA, 325, 542-551. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Ishan, L., Vangi, W.M., et al. (2021) Diagnostic and Prognostic Value of Serum C-Reactive Protein in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis. Heart Failure Reviews, 26, 1141-1150. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Lourenço, P., Pereira, J., Ribeiro, A., et al. (2019) C-Reactive Protein Decrease Associates with Mortality Reduction Only in Heart Failure with Preserved Ejection Fraction. Journal of Cardiovascular Medicine (Hagerstown), 20, 23-29. [Google Scholar] [CrossRef]
|
|
[16]
|
Prenner, S.B., Pillutla, R., Yenigalla, S., et al. (2020) Serum Albumin Is a Marker of Myocardial Fibrosis, Adverse Pulsatile Aortic Hemodynamics, and Prognosis in Heart Failure with Preserved Ejection Fraction. Journal of the American Heart Association, 9, e014716. [Google Scholar] [CrossRef]
|
|
[17]
|
Prenner, S.B., Kumar, A., Zhao, L., et al. (2020) Effect of Serum Albumin Levels in Patients with Heart Failure with Preserved Ejection Fraction (from the TOPCAT Trial). The American Journal of Cardiology, 125, 575-582. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Chahal, H., Bluemke, D.A., Wu, C.O., et al. (2015) Heart Failure Risk Prediction in the Multi-Ethnic Study of Atherosclerosis. Heart, 101, 58-64. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Januzzi, J.L., van Kimmenade, R., Lainchbury, J., et al. (2006) NT-proBNP Testing for Diagnosis and Short-Term Prognosis in Acute Destabilized Heart Failure: An International Pooled Analysis of 1256 Patients: The International Collaborative of NT-proBNP Study. European Heart Journal, 27, 330-337. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Kistorp, C., Raymond, I., Pedersen, F., et al. (2005) N-Terminal Pro-Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels as Predictors of Mortality and Cardiovascular Events in Older Adults. JAMA, 293, 1609-1616. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Yancy, C.W., Jessup, M., Bozkurt, B., et al. (2017) 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure. Journal of Cardiac Failure, 23, 628-651. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Mentz, R.J., Kelly, J.P., von Lueder, T.G., et al. (2014) Noncardiac Comorbidities in Heart Failure with Reduced versus Preserved Ejection Fraction. Journal of the American College of Cardiology, 64, 2281-2293. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Sato, Y., Yoshihisa, A., Oikawa, M., et al. (2019) Prognostic Impact of Chronic Obstructive Pulmonary Disease on Adverse Prognosis in Hospitalized Heart Failure Patients with Preserved Ejection Fraction: A Report from the JASPER Registry. Journal of Cardiology, 73, 459-465. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Hiriscau, E.I. and Bodolea, C. (2019) The Role of Depression and Anxiety in Frail Patients with Heart Failure. Diseases, 7, 45. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
史秀莉, 亢玉, 陈晨, 等. 心衰住院患者焦虑抑郁共病及其相关因素的研究[J]. 四川大学学报(医学版), 2017, 48(3): 435-440.
|
|
[26]
|
Sokoreli, I., de Vries, J.J.G., Pauws, S.C., et al. (2016) Depression and Anxiety as Predictors of Mortality among Heart Failure Patients: Systematic Review and Meta-Analysis. Heart Failure Reviews, 21, 49-63. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Alhurani, A.S., Dekker, R.L., Abed, M.A., et al. (2015) The Association of Co-Morbid Symptoms of Depression and Anxiety with All-Cause Mortality and Cardiac Rehospitalization in Patients with Heart Failure. Psychosomatics, 56, 371-380. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Chandra, A., Alcala, C.B., et al. (2020) Associations between Depressive Symptoms and HFpEF-Related Outcomes. JACC: Heart Failure, 8, 1009-1020. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Patel, R.B., Colangelo, L.A., Reiner, A.P., et al. (2020) Cellular Adhesion Molecules in Young Adulthood and Cardiac Function in Later Life. Journal of the American College of Cardiology, 75, 2156-2165. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Sinning, C., Kempf, T., Schwarzl, M., et al. (2017) Biomarkers for Characterization of Heart Failure—Distinction of Heart Failure with Preserved and Reduced Ejection Fraction. International Journal of Cardiology, 227, 272-277. [Google Scholar] [CrossRef] [PubMed]
|